BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 24421289)

  • 1. Interactive effects of OPRM1 and DAT1 genetic variation on subjective responses to alcohol.
    Ray LA; Bujarski S; Squeglia LM; Ashenhurst JR; Anton RF
    Alcohol Alcohol; 2014; 49(3):261-70. PubMed ID: 24421289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues.
    Schacht JP; Anton RF; Voronin KE; Randall PK; Li X; Henderson S; Myrick H
    Neuropsychopharmacology; 2013 Feb; 38(3):414-22. PubMed ID: 23032071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subjective response to alcohol among alcohol-dependent individuals: effects of the μ-opioid receptor (OPRM1) gene and alcoholism severity.
    Ray LA; Bujarski S; MacKillop J; Courtney KE; Monti PM; Miotto K
    Alcohol Clin Exp Res; 2013 Jan; 37 Suppl 1(Suppl 1):E116-24. PubMed ID: 23240711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid and Dopamine Genes Interact to Predict Naltrexone Response in a Randomized Alcohol Use Disorder Clinical Trial.
    Anton RF; Voronin KE; Book SW; Latham PK; Randall PK; Glen WB; Hoffman M; Schacht JP
    Alcohol Clin Exp Res; 2020 Oct; 44(10):2084-2096. PubMed ID: 32772383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent and Interactive Effects of OPRM1 and DAT1 Polymorphisms on Alcohol Consumption and Subjective Responses in Social Drinkers.
    Weerts EM; Wand GS; Maher B; Xu X; Stephens MA; Yang X; McCaul ME
    Alcohol Clin Exp Res; 2017 Jun; 41(6):1093-1104. PubMed ID: 28376280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naltrexone modification of drinking effects in a subacute treatment and bar-lab paradigm: influence of OPRM1 and dopamine transporter (SLC6A3) genes.
    Anton RF; Voronin KK; Randall PK; Myrick H; Tiffany A
    Alcohol Clin Exp Res; 2012 Nov; 36(11):2000-7. PubMed ID: 22551036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine].
    Kibitov АО; Krupitsky ЕМ; Blokhina ЕА; Verbitskaya ЕV; Brodyansky VМ; Alekseeva NP; Bushara NМ; Yaroslavtseva ТS; Palatkin VY; Masalov DV; Burakov АМ; Romanova ТN; Sulimov GY; Grinenko AY; Kosten Т; Nielsen D; Zvartau EE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):36-48. PubMed ID: 28300812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study.
    Ray LA; Hutchison KE
    Arch Gen Psychiatry; 2007 Sep; 64(9):1069-77. PubMed ID: 17768272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype.
    Ziauddeen H; Nestor LJ; Subramaniam N; Dodds C; Nathan PJ; Miller SR; Sarai BK; Maltby K; Fernando D; Warren L; Hosking LK; Waterworth D; Korzeniowska A; Win B; Richards DB; Vasist Johnson L; Fletcher PC; Bullmore ET
    Neuropsychopharmacology; 2016 Oct; 41(11):2647-57. PubMed ID: 27109624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of OPRM1 A118G and alcohol sensitivity with intravenous alcohol self-administration in young adults.
    Hendershot CS; Claus ED; Ramchandani VA
    Addict Biol; 2016 Jan; 21(1):125-35. PubMed ID: 25039301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The OPRM1 A118G polymorphism: converging evidence against associations with alcohol sensitivity and consumption.
    Sloan ME; Klepp TD; Gowin JL; Swan JE; Sun H; Stangl BL; Ramchandani VA
    Neuropsychopharmacology; 2018 Jun; 43(7):1530-1538. PubMed ID: 29497164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic Genetic Variation Influences Aripiprazole Effects on Alcohol Self-Administration and the Neural Response to Alcohol Cues in a Randomized Trial.
    Schacht JP; Voronin KE; Randall PK; Anton RF
    Neuropsychopharmacology; 2018 May; 43(6):1247-1256. PubMed ID: 29362512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of the mu-opioid receptor and dopamine D4 receptor genes and subjective responses to alcohol in the natural environment.
    Ray LA; Miranda R; Tidey JW; McGeary JE; MacKillop J; Gwaltney CJ; Rohsenow DJ; Swift RM; Monti PM
    J Abnorm Psychol; 2010 Feb; 119(1):115-25. PubMed ID: 20141248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 40-bp VNTR polymorphism in the 3'-untranslated region of DAT1/SLC6A3 is associated with ADHD but not with alcoholism.
    Šerý O; Paclt I; Drtílková I; Theiner P; Kopečková M; Zvolský P; Balcar VJ
    Behav Brain Funct; 2015 Jun; 11():21. PubMed ID: 26058807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study.
    Anton RF; Oroszi G; O'Malley S; Couper D; Swift R; Pettinati H; Goldman D
    Arch Gen Psychiatry; 2008 Feb; 65(2):135-44. PubMed ID: 18250251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine transporter (DAT1) VNTR polymorphism and alcoholism in two culturally different populations of south India.
    Bhaskar LV; Thangaraj K; Wasnik S; Singh L; Raghavendra Rao V
    Am J Addict; 2012; 21(4):343-7. PubMed ID: 22691013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in the dopamine transporter gene (SLC6A3/DAT1) and alcohol dependence in humans: a systematic review.
    van der Zwaluw CS; Engels RC; Buitelaar J; Verkes RJ; Franke B; Scholte RH
    Pharmacogenomics; 2009 May; 10(5):853-66. PubMed ID: 19450132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dopamine transporter VNTR polymorphism moderates the relationship between acute response to alcohol and future alcohol use disorder symptoms.
    Schacht JP; Anton RF; McNamara PJ; Im Y; King AC
    Addict Biol; 2019 Sep; 24(5):1109-1118. PubMed ID: 30230123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased mesolimbic cue-reactivity in carriers of the mu-opioid-receptor gene OPRM1 A118G polymorphism predicts drinking outcome: a functional imaging study in alcohol dependent subjects.
    Bach P; Vollsta Dt-Klein S; Kirsch M; Hoffmann S; Jorde A; Frank J; Charlet K; Beck A; Heinz A; Walter H; Sommer WH; Spanagel R; Rietschel M; Kiefer F
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1128-35. PubMed ID: 25937240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the Mu opioid receptor polymorphism (OPRM1 A118G) on pain regulation, placebo effects and associated personality trait measures.
    Peciña M; Love T; Stohler CS; Goldman D; Zubieta JK
    Neuropsychopharmacology; 2015 Mar; 40(4):957-65. PubMed ID: 25308352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.